Your browser doesn't support javascript.
loading
Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma.
Meyer, Yannick M; Beumer, Berend R; Höppener, Diederik J; Nierop, Pieter M H; Doukas, Michail; de Wilde, Roeland F; Sprengers, Dave; Vermeulen, Peter B; Verhoef, Cornelis; IJzermans, Jan N M.
Afiliação
  • Meyer YM; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Beumer BR; Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Rotterdam, the Netherlands.
  • Höppener DJ; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Nierop PMH; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • Doukas M; Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • de Wilde RF; Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Rotterdam, the Netherlands.
  • Sprengers D; Department of Gastroenterology and Hepatology, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Vermeulen PB; Translational Cancer Research Unit (GZA Hospitals and University of Antwerp), Antwerp, Belgium.
  • Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
  • IJzermans JNM; Erasmus MC Transplant Institute, Department of Surgery, Division of HPB & Transplant Surgery, Rotterdam, the Netherlands. Electronic address: j.ijzermans@erasmusmc.nl.
HPB (Oxford) ; 24(4): 507-515, 2022 04.
Article em En | MEDLINE | ID: mdl-34393042
ABSTRACT

BACKGROUND:

Microvascular invasion (MVI) is an established prognosticator in hepatocellular carcinoma (HCC). Histopathological growth patterns (HGPs) classify the invasive margin of hepatic tumors, with superior survival observed for the desmoplastic HGP. Our aim was to investigate non-cirrhotic HCC in light of MVI and the HGP.

METHODS:

A retrospective cohort study was performed in resected non-cirrhotic HCC. MVI was assessed prospectively. The HGP was determined retrospectively, blinded, and according to guidelines. Overall and disease-free survival (OS, DFS) were evaluated by Kaplan-Meier and multivariable Cox regression.

RESULTS:

The HGP was determined in 155 eligible patients, 55 (35%) featured a desmoplastic HGP. MVI was observed in 92 (59%) and was uncorrelated with HGP (64% vs 57%, p = 0.42). On multivariable analysis, non-desmoplastic and MVI-positive were associated with an adjusted HR [95%CI] of 1.61 [0.98-2.65] and 3.22 [1.89-5.51] for OS, and 1.59 [1.05-2.41] and 2.30 [1.52-3.50] for DFS. Effect modification for OS existed between HGP and MVI (p < 0.01). Non-desmoplastic MVI-positive patients had a 5-year OS of 36% (HR 5.21 [2.68-10.12]), compared to 60% for desmoplastic regardless of MVI (HR 2.12 [1.08-4.18]), and 86% in non-desmoplastic MVI-negative.

CONCLUSION:

HCCs in non-cirrhotic livers display HGPs which may be of prognostic importance, especially when combined with MVI.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article